Hybrid System with Biomethanation for Wind Energy Accumulation in the Baltic Countries

AbstractRenewable electrical energy use has great advantages, especially in case of solar and wind energy. Among these – resource sustainability is the biggest advantage. Some renewable energy resources are related to the irregularity of the energy source. One of the most promising technologies is biogas biomethanation with hydrogen, the model of which is analyzed in this article. The methodology developed allows one to analyze the broad spectrum of hybrid systems with biomethanation for wind energy accumulation where the accumulation of wind energy potential, on the one side, meets the interests of the biogas station which can utilize this energy

Carbon balance of biogas production from maize in Latvian conditions

Received: January 31st, 2021 ; Accepted: March 28th, 2021 ; Published: May 19th, 2021 ; Correspondence: [email protected] of biogas using bioresources of agricultural origin plays an important role in Europe’s energy transition to sustainability. However, many substrates have been denounced in the last years as a result of differences of opinion on its impact on the environment, while finding new resources for renewable energy is a global issue. The aim of the study is to use a carbon balance method to evaluate the real impact on the atmosphere by carrying out a carbon balance to objectively quantify naturally or anthropogenically added or removed carbon dioxide from the atmosphere. This study uses Latvian data to determine the environmental impact of biogas production depending on the choice of substrate, in this case from specially grown maize silage. GHG emissions from specially grown maize use and cultivation (including the use of diesel fuel, crop residue and nitrogen fertilizer incorporation, photosynthesis), biogas production leaks, as well as digestate emissions (including digestate emissions and also saved nitrogen emissions by the use of digestate) are taken into account when compiling the carbon balance of maize. The results showed that biogas production from specially grown maize can save 1.86 kgCO2eq emissions per 1 m3 of produced biogas

Opportunities for bioenergy in the Baltic Sea Region

Security of energy supply, promotion of the bio-economy, nutrient recycling, and innovation are prioritized policy areas in the EU Strategy for the Baltic Sea Region (EUBSR). The Baltic Sea Region (BSR) has a great bioenergy potential worth exploring in this context. This paper explores the state-of-art of bioenergy systems and synergies with eco-systems services in the BSR region in the context of developing the region’s bio-economy. In this brief assessment, we consider 8 countries (i.e. Sweden, Finland, Estonia, Latvia, Lithuania, Poland, Denmark, and Belarus) in the region. While the production and use of modern bioenergy can help reduce greenhouse gas (GHG) emissions, promote energy security, diversify energy resources, and contribute to a successful circular economy and rural development, it is important to find a balance between the exploration of resources and the management of eco-systems services. In addition, both climate change vulnerability and bioenergy production may affect the environment and the capacity of the BSR to deliver ecosystem services (ESS). We recommend integrated strategies for optimal use of bioresources in the region. Bioeconomy can be realized by innovative approaches, establishing cross-cutting institutional and policy linkages for increased prosperity and green growth in the Baltic Sea Region

Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapy

Allergen Specific Immunotherapy (SIT) for respiratory allergic diseases is able to significantly improve symptoms as well as reduce the need for symptomatic medication, but SIT also has the capacity for long-term clinical effects and plays a protective role against the development of further allergies and symptoms. The treatment acts on basic immunological mechanisms, and has the potential to change the pathological allergic immune response. In this paper we discuss some of the most important achievements in the documentation of the benefits of immunotherapy, over the last 2 decades, which have marked a period of extensive research on the clinical effects and immunological background of the mechanisms involved. The outcome of immunotherapy is described as different levels of benefit from early reduction in symptoms over progressive clinical effects during treatment to long-term effects after discontinuation of the treatment and prevention of asthma. The efficacy of SIT increases the longer it is continued and immunological changes lead to potential long-term benefits. SIT alone and not the symptomatic treatment nor other avoidance measures has so far been documented as the therapy with long-term or preventive potential. The allergic condition is driven by a subset of T-helper lymphocytes (Th2), which are characterised by the production of cytokines like IL-4, and IL-5. Immunological changes following SIT lead to potential curative effects. One mechanism whereby immunotherapy suppresses the allergic response is through increased production of IgG4 antibodies. Induction of specific IgG4 is able to influence the allergic response in different ways and is related to immunological effector mechanisms, also responsible for the reduced late phase hyperreactivity and ongoing allergic inflammation. SIT is the only treatment which interferes with the basic pathophysiological mechanisms of the allergic disease, thereby creating the potential for changes in the long-term prognosis of respiratory allergy. SIT should not only be recognised as first-line therapeutic treatment for allergic rhinoconjunctivitis but also as secondary preventive treatment for respiratory allergic diseases

Alternative “Green” Antimicrobial Agents Obtained by Selective Sorption from Lactobacillus plantarum Culture

According to the world health organization report from September 2016, the development of pathogenic bacteria resistance to antimicrobial drugs is one of the most important problems of the modern medicine. In this regard, the urgent task is the search for alternative antibiotics for the treatment of bacterial infections. One approach to solving this problem is obtaining antimicrobial compounds synthesized by probiotic lactic acid bacteria. The probiotic strain of Lactobacillus plantarum 8P-A3, was chosen to study its antimicrobial action. This strain produces at least two bacteriocins – plantaricin EF and plantaricin NC8. The chromatographic isolation of peptide fractions from the supernatant was carried out using a polymer sorbent based on methacrylic acid and ethyleneglycol dimethacrylate. Optimal parameters for chromatographic process were determined. It is shown that all the target biologically active substances were bound with the sorbent in sorption at acidic pH values. Elution was performed in isocratic mode. The antimicrobial activity of the obtained peptide fractions against indicator culture was determined by turbidimetric method. During incubation process, the turbidity of the microbial suspension was determined by measuring the optical density at λ = 600 nm. It is revealed that the fraction obtained at rinse by eluent with pH 8 has the maximum inhibitory ability. Сhromatomass-spectrometry analysis of the peptide fraction was carried out using Shimadzu LCMS-8040.The antimicrobial activity of the fraction is comparable to the action of ampicillin against gram-negative bacteria Escherichia coli. To confirm the peptide nature of the antimicrobial activity of the fraction, an indicator culture was incubated with the fraction treated with proteolytic enzymes (trypsin). It is determined the fraction can be stored at −18 °C and saves antimicrobial properties after defrosting